National Comprehensive Cancer Network

About NCCN

Global Representation at the NCCN 21st Annual Conference General Poster Session

The National Comprehensive Cancer Network® (NCCN®) will hold its 4th annual General Poster Session during the NCCN 21st Annual Conference: Advancing the Standard of Cancer Care™, in Hollywood, Florida on 31 March – 1 April , 2016.  NCCN accepted 72 original abstracts for presentation, authored by investigators from academic institutions, teaching and community hospitals, and industry.                             

This year, six abstracts were accepted from investigators outside the United States:

  • Robert Hawkins; MA, MB, BS, PhD, FRCP; Cancer Research UK, Manchester, UK Great Britain
    • Real-World Treatment Patterns and Characteristics Associated with Systemic Therapy in Patients with Advanced Renal Cell Carcinoma: Results from a United States Cohort Chart Review
  • Guillaume Hébert; MSc; Gustave Roussy—France, Ecoles de Hautes Etudes en Sante’ Publique, IATRIGGER Work Group, Villejuif, France
    • Evaluating Iatrogenic Prescribing in Oncology: Consensual Establishment of a List of Preventable Adverse Drug Events
  • Shiv Rajan; MCh, MS, MBBS; King George’s Medical University, Lucknow, India
    • Clinical Values of Serum CA 125 & Human Epididymis Protein 4 (HE4) in Predicting Optimal Cytoreduction after Neoadjuvant Chemotherapy in Advance Stage Ovarian Carcinoma
  • Jayapala Reddy; MBBS, MS; Jawaharlal Institute of Post-Graduate Medical Education and Research (JIPMER), Pondicherry, India
    • Factors Potentially Influencing the Clinical Outcome of Small Bowel Complications Following Pelvic Irradiation – A Hospital-Based Prospective Observational Study
  • Zeng Wang, MD; Zhejiang Cancer Hospital, Hangzhou, China
    • Cooperation of Clinical Pharmacists and Physicians in Management of Cancer Pain: Results from a Retrospective Analysis in Chinese Population
    • Factors Potentially Associated with Gemcitabine-Based Chemotherapy-Induced Thrombocytopenia in Chinese Patients with Non-Small Cell Lung Cancer

Abstracts were evaluated using a peer‐review process. Oncology research faculty from NCCN Member Institutions served as peer reviewers to approve research for display during the General Poster Session. All approved original abstracts will be published online at Select, top scoring, abstracts will also be published in print in the May 2016 “Highlights” issue of JNCCN — Journal of the National Comprehensive Cancer Network.